Lunaphore to launch The Spatial Biology Tour™ 2023 Europe to accelerate the adoption of spatial biology

Lunaphore to launch The Spatial Biology Tour™ 2023 Europe to accelerate the adoption of spatial biology

LAUSANNE, Switzerland – August 28, 2023 – 4:00 pm (CEST) Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, today announced the return of The Spatial Biology Tour™, taking place in person during the fall hosted by prominent research institutes across Europe. The one-day seminars aim to connect scientists and industry to accelerate the adoption of spatial biology by showcasing cutting-edge technologies and assisting learning.

The activities planned around The Spatial Biology Tour™ will explore how the next generation of scalable spatial biology solutions and scientific collaboration can advance research and help scientists gain a profound knowledge of the underlying pathophysiological states of diseases. These innovative approaches could pave the way for personalized diagnostics and therapies by lowering the barriers that currently prevent the broad adoption of spatial biology.

During the day, local scientists will have the opportunity to discover Lunaphore’s COMET™ portfolio, the first universal, end-to-end spatial biology solution, explore use cases in recent peer-reviewed publications, and listen to key opinion leaders sharing their research work. In addition, the seminars will include dedicated networking sessions, and Lunaphore will present a comprehensive physical or live-streamed instrument demonstration at some institutes.

Confirmed stops of The Spatial Biology Tour™ 2023:

  • September 12: University of Zurich, Zurich, Switzerland
  • September 18: Medical University of Vienna, Vienna, Austria
  • October 9: German Cancer Research Center (DFKZ), Heidelberg, Germany
  • October 12: University Hospital Hamburg-Eppendorf, Hamburg, Germany
  • October 16: Cancer Research UK Beatson Institute, Glasgow, United Kingdom
  • October 17: The University of Edinburgh, Edinburgh, United Kingdom
  • October 18: University of Oslo, Oslo, Norway
  • October 19: University of Oxford, Oxford, United Kingdom
  • October 26: KU Leuven, Leuven, Belgium
  • October 27: PARCC – European Hospital Georges Pompidou, Paris, France
  • October 30: Institute for Research in Biomedicine, Barcelona, Spain
  • October 31: Teofilo Hernando Foundation Institute, Madrid, Spain
  • November 9: SciLifeLab, Stockholm, Sweden



To register and learn more about the event and the agenda, please visit:

To learn more about COMET™, please visit:

To learn more about Lunaphore, please visit:


About Lunaphore

Lunaphore Technologies S.A. is a Swiss company born in 2014 with the vision of enabling spatial biology in every laboratory. Lunaphore provides solutions based on a game-changing chip technology that can extract spatial proteomic and transcriptomic data from tumors and other tissues, transforming any assay into multiplex spatial biology through a streamlined and easily integrated process. Lunaphore empowers researchers in immunology, immuno-oncology, and neuroscience to push the boundaries of scientific discovery and drug development. Lunaphore’s technology enables the identification of biomarker “signatures” with clinical relevance to support the development of diagnostic tools and streamline clinical trials, to ultimately improve patient outcomes. For further information on Lunaphore and its products, please visit


About COMET™

COMET™ is the only fully automated, high-throughput, hyperplex platform ensuring scalability and reproducibility without the need to conjugate primary antibodies. COMET™ provides walk-away automation, integrating staining, imaging, and image preprocessing steps to obtain standard hyperplex images. COMET™ generates highly robust and reproducible data with full tissue preservation, allowing researchers to perform downstream modalities such as H&E or transcriptomics using the same slide. Its superior tissue profiling capabilities facilitate the analysis of 40 different spatial markers in each automated run on a tissue slide. In contrast to other spatial biology solutions, COMET™ works with off-the-shelf, label-free primary antibodies, making panel design much more flexible and faster than any other hyperplex solution. COMET™ works with regular glass slides from standard histology workflows; it is validated for human and mouse samples and is compatible with any other animal sample. The platform can be used for a wide range of research applications, allowing for a dramatic improvement in the understanding of disease pathology. Orders of the new COMET™ version can be placed and will be available for shipment in the upcoming months. To learn more about the COMET™ platform, please visit:


For further information contact:

Irene Tamayo
Lunaphore Corporate Communications
Email: [email protected]